Thursday, 16 January 2014

‘Viagra for women’ on the horizon…and it could even help you lose weight!

Viagra for women has been a topic of great debate ever since Pfizer Viagra first became available way back in 1998, approved for the treatment of erectile dysfunction.

However, that could be a reality by the end of next year as scientists conduct trials on a new wonder drug that almost sounds like it is too good to believe. Not only will be the tablet provide a boost to the woman’s sex drive, but it will apparently also help to curb their appetite and lose weight.

ORLIBID, the British company involved in developing the drug, are optimistic they will be successful in having ‘ORL101’ on shelves by the end of 2015.

An estimated four in ten women complain at some point that their sex life is larking the spark it once had and drug companies have toiled for a number of years to create a female equivalent of the hugely popular but still male-only Viagra – Pfizer’s sixth-biggest medicine, with annual sales of about $2 billion (£1.22 billion).

A strong psychological factor linked to a woman’s libido makes it difficult for pharmaceutical companies to create something effective and beneficial.

Dr Mike Wyllie, part of the team behind the development of Viagra, is of the opinion that ORLIBID could hold the key to unlocking the problem of a woman’s sex drive, and possibly succeed where others have not.

Increasing the brain to desire, ORL101 is a synthetic version of melatonin, which those with a penchant for tanning may have heard of.

Many experts have already been aware of melatonin’s ability to boost sex drive, but the task of getting it into a pill, as opposed to an injection, has proved a complex task.
The cost of ORL101 is anyone’s guess but it is assumed the drug will be comparable to Viagra’s price when it initially launched; up to £12 a tablet.

The tablet will only need to be taken 15 minutes prior to sex, providing a boost to the woman’s libido for up to an impressive 2 hours. This conclusion has been derived from studies conducted on jabs with comparable formulas, which led to better sex and a decreased appetite too.

Dr Wyllie is offering his services to ORLIBID on an advisory basis, free of charge, and will not profit from sales. He says: “It will be for everyone from those where female sexual dysfunction is destroying their relationships to those just wanting to spice up their sex life.”

Dr John Dean, a former president of the International Society for Sexual Medicine, said a drug could be ideal when no medical or psychological cause for sexual problems is found.

He added: “Low sexual desire is by no means a trivial problem. It affects lives, relationships, productivity and satisfaction.”

No comments:

Post a Comment